Supreme Court temporarily extends women’s access to a widely used abortion pill

The Supreme Court has temporarily maintained access to the abortion pill mifepristone, allowing women to obtain it without visiting a doctor in person. This decision comes as the justices consider whether to enforce restrictions imposed by a federal appeals court. The case originated from a lawsuit by Louisiana, challenging the FDA’s rules on mifepristone, which has been deemed safe by the FDA since its approval in 2000. The drug is commonly used with misoprostol for medication abortions, which made up nearly two-thirds of U.S. abortions in 2023. The Supreme Court previously blocked similar restrictions and dismissed a related lawsuit in 2024. Medical groups and the pharmaceutical industry warn that limiting access could disrupt the drug approval process. Despite ongoing challenges, the FDA has eased restrictions on mifepristone over the years. QUESTION: How might changes in access to medication like mifepristone impact young people’s views on healthcare and personal rights?